Search results
William Sellers is a core institute member of the Broad Institute of MIT and Harvard and serves as director of the institute's Cancer Program. He is also a faculty member at Harvard Medical School (HMS), and faculty member and senior advisor to the president for experimental therapeutics at Dana-Farber Cancer Institute (DFCI). He is a distinguished cancer scientist, with deep experience in ...
William Sellers. The long-term goal of Sellers lab is to deeply investigate cancer dependent genes to inform therapeutic discovery in cancer. The approaches to this problem have taken three forms. First, while at the Dana-Farber Cancer Institute and Broad Institute, together with Matthew Meyerson we pioneered genome scale approaches to the ...
William Sellers. The long-term goal of Sellers lab is to deeply investigate cancer dependent genes to inform therapeutic discovery in cancer. The approaches to this problem have taken three forms. First, while at the Dana-Farber Cancer Institute and Broad Institute, together with Matthew Meyerson we pioneered genome scale approaches to the ...
2000. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. ME McMenamin, P Soung, S Perera, I Kaplan, M Loda, WR Sellers. Cancer research 59 (17), 4291-4296. , 1999. 921. 1999. Articles 1–20. Core Institute Member, The Broad Institute - Cited by 97,065 ...
People also ask
Who is William Sellers?
Who owns William Sellers & Co?
Who is Thomas Sellers?
What did William Sellers do for a living?
Nov 22, 2016 · William Sellers, a widely-respected cancer researcher with deep experience in cancer genomics and therapeutic discovery, is returning to the Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute (DFCI), and Harvard Medical School (HMS) as a faculty member.
Systematic elucidation of cancer dependencies. Leveraging the CCLE, within Novartis, Bill Sellers led the efforts to annotate the gene-level functional requirements for 7,700 genes targeted by an average of 20 shRNA per gene in 390+ cell lines. These efforts led to the discovery of PRMT5 as a synthetic lethal node downstream of the co-deletion ...
William Sellers. Human-like external function of the foot, and fully upright gait, confirmed in the 3.66 million year old Laetoli hominin footprints by topographic statistics, experimental …. RH Crompton, TC Pataky, R Savage, K D'août, MR Bennett, MH Day, ...
